Dianxing Sun

1.4k total citations
45 papers, 1.1k citations indexed

About

Dianxing Sun is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Dianxing Sun has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 17 papers in Hepatology and 12 papers in Molecular Biology. Recurrent topics in Dianxing Sun's work include Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (12 papers) and Liver Disease Diagnosis and Treatment (10 papers). Dianxing Sun is often cited by papers focused on Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (12 papers) and Liver Disease Diagnosis and Treatment (10 papers). Dianxing Sun collaborates with scholars based in China, Germany and Australia. Dianxing Sun's co-authors include Michael Nassal, Fubiao Kang, Dong Li, Pengyu Han, Haijun Li, Wang Ling, Christine Bernsmeier, Markus H. Heim, Verena Christen and François H.T. Duong and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Dianxing Sun

45 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dianxing Sun China 17 448 399 337 233 187 45 1.1k
Romain Parent France 18 563 1.3× 351 0.9× 539 1.6× 145 0.6× 87 0.5× 39 1.2k
Zhijun Su China 17 267 0.6× 310 0.8× 194 0.6× 280 1.2× 125 0.7× 47 822
Ankit Bhatta United States 7 320 0.7× 596 1.5× 238 0.7× 160 0.7× 63 0.3× 9 1.0k
Tobias Mueller Germany 18 503 1.1× 244 0.6× 426 1.3× 354 1.5× 222 1.2× 33 1.3k
Andrew E. Greenstein United States 17 295 0.7× 497 1.2× 225 0.7× 167 0.7× 181 1.0× 37 1.1k
Xiaojun Hu China 18 166 0.4× 264 0.7× 170 0.5× 127 0.5× 75 0.4× 65 1.2k
Cheng-Fu Kuo United States 8 584 1.3× 255 0.6× 265 0.8× 246 1.1× 327 1.7× 10 1.0k
Garwin Sing United States 18 223 0.5× 358 0.9× 92 0.3× 403 1.7× 161 0.9× 35 1.0k
Hien Dang United States 16 130 0.3× 684 1.7× 156 0.5× 157 0.7× 296 1.6× 28 1.2k
Ivan Borozan Canada 13 373 0.8× 350 0.9× 473 1.4× 208 0.9× 165 0.9× 16 1.0k

Countries citing papers authored by Dianxing Sun

Since Specialization
Citations

This map shows the geographic impact of Dianxing Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianxing Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianxing Sun more than expected).

Fields of papers citing papers by Dianxing Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianxing Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianxing Sun. The network helps show where Dianxing Sun may publish in the future.

Co-authorship network of co-authors of Dianxing Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Dianxing Sun. A scholar is included among the top collaborators of Dianxing Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianxing Sun. Dianxing Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chaoqun, Dianxing Sun, Huifang Zhou, et al.. (2025). Autophagy-related long non-coding RNA MIR210HG plays a therapeutic role in hepatocellular carcinoma. Discover Oncology. 16(1). 75–75. 3 indexed citations
2.
Wang, Yan, et al.. (2021). Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury. Scientific Reports. 11(1). 11642–11642. 4 indexed citations
3.
Zhou, Huifang, et al.. (2020). <p>Combination of CpG Oligodeoxynucleotide and Anti-4-1BB Antibody in the Treatment of Multiple Hepatocellular Carcinoma in Mice</p>. OncoTargets and Therapy. Volume 13. 6997–7005. 1 indexed citations
4.
Zhou, Huifang, Libo Su, Chao Liu, et al.. (2019). <p>CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma</p>. OncoTargets and Therapy. Volume 12. 7823–7831. 19 indexed citations
5.
Han, Pengyu, et al.. (2019). Epidemiology survey of infectious diseases in North Korean travelers, 2015–2017. BMC Infectious Diseases. 19(1). 13–13. 5 indexed citations
6.
Li, Hui, Sufang Fan, Yan Wang, Shigang Shen, & Dianxing Sun. (2017). Rapid Detection of Small Molecule Metabolites in Serum of Hepatocellular Carcinoma Patients Using Ultrafast Liquid Chromatography-Ion Trap-Time of Flight Tandem Mass Spectrometry. Analytical Sciences. 33(5). 573–578. 9 indexed citations
7.
Wang, Yang, Jinghua Du, Na Fu, et al.. (2017). MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2. Cell Death and Disease. 8(5). e2792–e2792. 65 indexed citations
8.
Kang, Fubiao, Ling Wang, & Dianxing Sun. (2017). Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy. Medicine. 96(44). e8518–e8518. 5 indexed citations
9.
Han, Pengyu, et al.. (2016). Interaction between periodontitis and liver diseases. Biomedical Reports. 5(3). 267–276. 58 indexed citations
10.
Li, Baosheng, Xin Cheng, Haijun Li, et al.. (2016). Suppression of hepatitis B virus antigen production and replication by wild-type HBV dependently replicating HBV shRNA vectors in vitro and in vivo. Antiviral Research. 134. 117–129. 9 indexed citations
11.
Sun, Dianxing, et al.. (2016). Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications. Biomedical Reports. 4(5). 528–534. 129 indexed citations
12.
Sun, Dianxing, et al.. (2016). Mean arterial pressure drop is an independent risk factor of death in patients with HBV-related cirrhosis ascites. The Turkish Journal of Gastroenterology. 28(1). 26–30. 1 indexed citations
15.
Kang, Fubiao, et al.. (2014). Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression. Oncology Reports. 33(1). 274–282. 67 indexed citations
16.
Su, Shanshan, Huan He, Lingbo Kong, et al.. (2014). Regulatory Phenotype, PD-1 and TLR3 Expression in T Cells and Monocytes from HCV Patients Undergoing Antiviral Therapy: A Randomized Clinical Trial. PLoS ONE. 9(4). e93620–e93620. 10 indexed citations
17.
Wu, Li‐Ling, Xin Cheng, Baosheng Li, et al.. (2013). Replication-Competent Infectious Hepatitis B Virus Vectors Carrying Substantially Sized Transgenes by Redesigned Viral Polymerase Translation. PLoS ONE. 8(4). e60306–e60306. 19 indexed citations
18.
Sun, Dianxing, Christine Rösler, Karin Kidd‐Ljunggren, & Michael Nassal. (2010). Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites. Journal of Hepatology. 52(6). 817–826. 32 indexed citations
19.
Sun, Dianxing & Michael Nassal. (2006). Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. Journal of Hepatology. 45(5). 636–645. 106 indexed citations
20.
Nassal, Michael, Kai Dallmeier, Ursula Schultz, & Dianxing Sun. (2005). Phenotyping hepatitis B virus variants: From transfection towards a small animal in vivo infection model. Journal of Clinical Virology. 34. S89–S95. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026